Zhijian Qian

Zhijian Qian

Auto-generated profile, based on publicly available information

Zhijian Qian

Department of Medicine, UF Health Cancer Center, University of Florida, Gainesville, FL 32610, USA

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2019 in Cancer Cell
Verified
Journal Article
Closed access
YHYue Huang
Yue Huang
RSRui Su
Rui Su
YSYue Sheng
Yue Sheng
LDLei Dong
Lei Dong
ZDZe Dong
Ze Dong
CYCai-Guang Yang
Cai-Guang Yang

12 May 2020 in Cell Stem Cell
Verified
Journal Article
Closed access
CSChao Shen
Chao Shen
YSYue Sheng
Yue Sheng
AZAllen C. Zhu
Allen C. Zhu
SRSean Robinson
Sean Robinson
XJXi Jiang
Xi Jiang
JCJianjun Chen
Jianjun Chen

28 May 2021 in Nucleic Acids Research
Verified
Journal Article
Open access
PDF file
FYFang Yu
Fang Yu
JWJiangbo Wei
Jiangbo Wei
XCXiaolong Cui
Xiaolong Cui
CYChunjie Yu
Chunjie Yu
WNWei Ni
Wei Ni
ZQZhijian Qian
Zhijian Qian
Faithful genome integrity maintenance plays an essential role in cell survival. Here, we identify the RNA demethylase ALKBH5 as a key regulator that protects cells from DNA damage and apoptosis during reactive oxygen species (ROS)-induced stress. We find that ROS significantly induces global mRNA N6-methyladenosine (m6A) levels by modulating ALKBH5 post-translational modifications (PTMs), leading to the rapid and efficient induction of thousands of genes involved in a variety of biological processes including DNA damage repair. Mechanistically, ROS promotes ALKBH5 SUMOylation through activating ERK/JNK signaling, leading to inhibition of ALKBH5 m6A demethylase activity by blocking substrate accessibility. Moreover, ERK/JNK/ALKBH5-PTMs/m6A axis is activated by ROS in hematopoietic stem/progenitor cells (HSPCs) in vivo in mice, suggesting a physiological role of this molecular pathway in the maintenance of genome stability in HSPCs. Together, our study uncovers a molecular mechanism involving ALKBH5 PTMs and increased mRNA m6A levels that protect genomic integrity of cells in response to ROS.

30 December 2021 in Blood
Verified
Journal Article
Open access
PDF file
YSYue Sheng
Yue Sheng
JWJiangbo Wei
Jiangbo Wei
FYFang Yu
Fang Yu
HXHuanzhou Xu
Huanzhou Xu
CYChunjie Yu
Chunjie Yu
ZQZhijian Qian
Zhijian Qian
YTHDC1 has distinct functions as a nuclear N6-methyladenosine (m6A) reader in regulating RNA metabolism. Here we show that YTHDC1 is overexpressed in acute myeloid leukemia (AML) and that it is required for the proliferation and survival of human AML cells. Genetic deletion of Ythdc1 markedly blocks AML development and maintenance as well as self-renewal of leukemia stem cells (LSCs) in vivo in mice. We found that Ythdc1 is also required for normal hematopoiesis and hematopoietic stem and progenitor cell (HSPC) maintenance in vivo. Notably, Ythdc1 haploinsufficiency reduces self-renewal of LSCs but not HSPCs in vivo. YTHDC1 knockdown has a strong inhibitory effect on proliferation of primary AML cells. Mechanistically, YTHDC1 regulates leukemogenesis through MCM4, which is a critical regulator of DNA replication. Our study provides compelling evidence that shows an oncogenic role and a distinct mechanism of YTHDC1 in AML.

17 February 2020 in Nature Communications
Verified
Journal Article
Open access
PDF file
YSYue Sheng
Yue Sheng
CYChunjie Yu
Chunjie Yu
YLYin Liu
Yin Liu
CHChao Hu
Chao Hu
RMRui Ma
Rui Ma
ZQZhijian Qian
Zhijian Qian
FOXM1, a known transcription factor, promotes cell proliferation in a variety of cancer cells. Here we show that Foxm1 is required for survival, quiescence and self-renewal of MLL-AF9 (MA9)-transformed leukemia stem cells (LSCs) in vivo. Mechanistically, Foxm1 upregulation activates the Wnt/β-catenin signaling pathways by directly binding to β-catenin and stabilizing β-catenin protein through inhibiting its degradation, thereby preserving LSC quiescence, and promoting LSC self-renewal in MLL-rearranged AML. More importantly, inhibition of FOXM1 markedly suppresses leukemogenic potential and induces apoptosis of primary LSCs from MLL-rearranged AML patients in vitro and in vivo in xenograft mice. Thus, our study shows a critical role and mechanisms of Foxm1 in MA9-LSCs, and indicates that FOXM1 is a potential therapeutic target for selectively eliminating LSCs in MLL-rearranged AML.

30 May 2023 in Molecular Cell
Verified
Journal Article
Closed access
FYFang Yu
Fang Yu
AZAllen C. Zhu
Allen C. Zhu
SLShun Liu
Shun Liu
BGBoyang Gao
Boyang Gao
YWYuzhi Wang
Yuzhi Wang
ZQZhijian Qian
Zhijian Qian